This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Jump to section
Related Articles
Cited By...
- Report on the PET/CT Image-Based Radiation Dosimetry of [18F]FDHT in Women, a Validated Imaging Agent with New Applications for Evaluation of Androgen Receptor Status in Women with Metastatic Breast Cancer
- Report on the PET/CT Image-Based Radiation Dosimetry of [18F]FDHT in Women, a Validated Imaging Agent with New Applications for Evaluation of Androgen Receptor Status in Women with Metastatic Breast Cancer
- Imaging Androgen Receptors in Breast Cancer with 18F-Fluoro-5{alpha}-Dihydrotestosterone PET: A Pilot Study
- Assessment of Simplified Methods for Quantification of 18F-FDHT Uptake in Patients with Metastatic Castration-Resistant Prostate Cancer
- Evaluation of Castration-Resistant Prostate Cancer with Androgen Receptor-Axis Imaging
- Measuring Oncogenic Signaling Pathways in Cancer with PET: An Emerging Paradigm from Studies in Castration-Resistant Prostate Cancer
- Pharmacokinetic Assessment of the Uptake of 16{beta}-18F-Fluoro-5{alpha}-Dihydrotestosterone (FDHT) in Prostate Tumors as Measured by PET
- The Importance of Kinetic Enhancement
- Radiopharmaceuticals in Preclinical and Clinical Development for Monitoring of Therapy with PET
- Imaging Surrogates of Tumor Response to Therapy: Anatomic and Functional Biomarkers
- Tumor Receptor Imaging
- 7{alpha}-18F-Fluoromethyl-Dihydrotestosterone and 7{alpha}-18F-Fluoromethyl-Nortestosterone: Ligands to Determine the Role of Sex Hormone-Binding Globulin for Steroidal Radiopharmaceuticals
- 18F-Fluoroacetate: A Potential Acetate Analog for Prostate Tumor Imaging--In Vivo Evaluation of 18F-Fluoroacetate Versus 11C-Acetate
- Positron Emission Tomography As an Imaging Biomarker
- Preclinical Pharmacology of a Nonsteroidal Ligand for Androgen Receptor-Mediated Imaging of Prostate Cancer
- The Progress and Promise of Molecular Imaging Probes in Oncologic Drug Development
- PET-Based Radiation Dosimetry in Man of 18F-Fluorodihydrotestosterone, a New Radiotracer for Imaging Prostate Cancer
- Receptor Imaging in Oncology by Means of Nuclear Medicine: Current Status
- microPET and Autoradiographic Imaging of GRP Receptor Expression with 64Cu-DOTA-[Lys3]Bombesin in Human Prostate Adenocarcinoma Xenografts
- Tumor Localization of 16{beta}-18F-Fluoro-5{alpha}-Dihydrotestosterone Versus 18F-FDG in Patients with Progressive, Metastatic Prostate Cancer